Avience Biomedicals IPO Final Subscription Status

Final subscription data from BSE & NSE with category-wise breakdowns

📈 Building steadily
📈 GMP Today 🎟️ Allotment Status 📄 Full IPO Details Listed at NSE · Registrar: Skyline Financial Services Pvt. Ltd.
Listed SME

Avience Biomedicals

Price: ₹196 - ₹208 Lot: 1200 Min: ₹2,49,600 Period: 18 Jun - 22 Jun
Subscribed
385.40x
Total Demand
₹7,710 Cr
Applications
1,92,952
Build by Day
10.51x → 43.38x → 385.4x

Subscription (Shares)

CategoryOfferedAppliedTimes
QIB 2,73,600 5,38,37,400 196.77
NII 2,07,000 12,37,09,800 597.63
bNII (>10 Lakh) 1,38,000 9,25,66,800 670.77
sNII (2-10 Lakh) 69,000 3,11,43,000 451.35
Retail 4,81,200 19,31,32,800 401.36
TOTAL 9,61,800 37,06,80,000 385.40

Application Breakup

CategoryReservedApplicationsTimes
NII 115 31,836 276.83
bNII (>10 Lakh) 77 16,492 214.18
sNII (2-10 Lakh) 38 15,344 403.79
Retail 401 1,60,944 401.36
TOTAL 631 1,92,952 305.79

Subscription (Crores)

CategoryOfferedDemandTimes
QIB 5.69 1,119.82 196.77
NII 4.31 2,573.16 597.63
bNII (>10 Lakh) 2.87 1,925.39 670.77
sNII (2-10 Lakh) 1.44 647.77 451.35
Retail 10.01 4,017.16 401.36
TOTAL 20.01 7,710.14 385.40
View IPO Details →

Day-wise Subscription

How demand built up across the bidding days — subscription at the end of each day.

Each panel uses its own scale; compare the numbers, not bar heights, across categories.
Day QIB NII bNII sNII Retail Total
Day 1 18 Jun 0.00x 13.43x 13.66x 12.96x 15.23x 10.51x
Day 2 19 Jun 0.03x 66.63x 66.67x 66.56x 58.02x 43.38x
Day 3 22 Jun 196.77x 597.63x 670.77x 451.35x 401.36x 385.40x

Estimated Allotment Chance

Retail 0.28% (401.36x subscribed)
Low chance
S-HNI (2-10L) 0.22% (451.35x subscribed)
Low chance
B-HNI (>10L) 0.75% (670.77x subscribed)
Low chance
about 3 in 1,000 retail applicants are likely to get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.
Full allotment calculator →
Disclaimer: Subscription data is sourced from BSE and NSE. Please verify with official exchange websites before making any investment decisions. This information is for educational purposes only and should not be construed as investment advice.

Avience Biomedicals IPO Subscription — Detailed Analysis

Where Avience Biomedicals Subscription Finished

Avience Biomedicals IPO was subscribed 385.40 times overall by the close of bidding — a heavily oversubscribed level that signals strong investor demand. A total of 1,92,952 applications were received.

Avience Biomedicals IPO Subscription — FAQs

Avience Biomedicals IPO was subscribed 385.40 times overall by the close of bidding.

Avience Biomedicals IPO was open for subscription from June 18, 2026 to June 22, 2026.

The price band for Avience Biomedicals IPO is ₹196 - ₹208 per share.

New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.

Explore More

Quick links to all IPO sections

▶️ Open IPO Live now ⭐ Best IPO Today Data scores 📅 Upcoming IPO Coming soon 📆 IPO Calendar Dates & schedule ✔️ Closed IPO Allotment pending 📈 Listed IPO Listing gains 🔥 IPO GMP Grey market premium 📊 Subscription Live bidding data 🏆 Allotment Check status 🎯 Allotment Chances Your odds 🏢 SME IPO Small & medium 🏦 Mainboard IPO Large cap 💰 Performance Listing returns 📚 Learn IPO guides
GMPUpdate